
April 26 (Reuters) - Valneva SE VLS.PA:
VALNEVA PROVIDES UPDATE ON RECOMMENDATION FOR USE OF ITS CHIKUNGUNYA VACCINE BY FRENCH AUTHORITIES
VALNEVA SE: ON APRIL 25, FRENCH HEALTH AUTHORITIES DECIDED TO SUSPEND USE OF IXCHIQ® IN PERSONS AGED 65 YEARS AND OLDER PENDING FURTHER INVESTIGATION
VALNEVA SE - THREE SAES, INCLUDING ONE DEATH, REPORTED AFTER IXCHIQ VACCINATION
VALNEVA SE - HAS MAINTAINS IXCHIQ RECOMMENDATION FOR AGES 18-64